Skip to main content

Table 4 Clinical characteristics of the validation cohort

From: Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis

Ā 

Sarcoidosis

Other ILDs

Number of patients

8

45

Number of lymphocytes analyzed

439

2662

Age

56.3ā€‰Ā±ā€‰5.0

65.0ā€‰Ā±ā€‰2.0

Gender (male/female)

3/5

25/20

Smkoking (yes/no)

4/4

23/21 (NR: 1)

Ā IIPs (COP or AIP)

Ā 

5

Ā IIPs (uILD)

Ā 

5

Ā CTD-ILD

Ā 

12

Ā HP

Ā 

4

Ā DILD

Ā 

11

Ā Infection

Ā 

2

Ā Others

Ā 

6

  1. ILD, interstitial lung disease; NR, not reported; IIP, idiopathic interstitial pneumonia; COP, cryptogenic organizing pneumonia; AIP, acute interstitial pneumonia; uILD, unclassifiable interstitial lung disease; CTD-ILD, connective tissue disease-associated interstitial lung disease; HP, hypersensitivity pneumonia; DILD, drug-induced interstitial lung disease